Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Filed Aug 13, 2024 · 10-Q · 44 days after period end · 0001753926-24-001419
| Metric | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|
| Revenue | $136.43K | $106.68K | $0.00 |
| Net Income | -$938.15K | -$1.54M | -$782.02K |
| EPS Diluted | -$0.99 | -$0.27 | -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 13, 2024 · 44 d after period end
